GLAXO

2,575 INR
25.8001
0.99%
Last update Dec 15, 3:29 PM IST
Main market
Day range
2,573.39990
2,607.60010
Previous close
2,600.80005
Open
2,587
Access this stock data via API
Subscribe
GlaxoSmithKline Pharmaceuticals Ltd.
2,575.00
25.80
0.99%

Financials

Income statement

Fiscal date Jun 2025 Mar 2025 Dec 2024 Sep 2024
Total reported revenue 8.1B 9.5B 9.5B 10.1B
Cost of revenue 2.9B 4.3B 3.6B 3.8B
Gross profit 5.2B 5.2B 5.9B 6.3B
Operating expense
Research & development
Selling general and admin
Other operating expenses 1.1B -1.9B 1.7B 1.5B
Operating income 2.4B 3.2B 2.7B 3.0B
Non operating interest income
Income
Expense 4.2M 5.8M 900K 2.7M
Other income expense
Pretax income 2.8B 3.6B 3.1B 3.4B
Tax provision 739.7M 957.0M 782.2M 913.1M
Net income 2.1B 2.6B 2.3B 2.5B
Basic EPS 12.1 13.6 14.9
Diluted EPS 12.1 13.6 14.9
Basic average shares 169.4M 169.4M 169.3M
Diluted average shares 169.4M 169.4M 169.3M
EBITDA 2.9B 3.1B 3.3B 3.6B
Net income from continuing op.
Minority interests
Preferred stock dividends 0 0 0 0
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 3 hours 43 minutes

11:46
00:00
09:15
15:30
23:59

Trading Hours (Sunday - Thursday):

Main market
09:15 - 15:30
All times are displayed in the Asia/Kolkata timezone (IST, UTC+05:30).